Combined immunization against TGF-β1 enhances HPV16 E7-specific vaccine-elicited antitumour immunity in mice with grafted TC-1 tumours-Reference-Cited by-同舟云学术

Combined immunization against TGF-β1 enhances HPV16 E7-specific vaccine-elicited antitumour immunity in mice with grafted TC-1 tumours

Published:2018-06-22 Issue:sup2 Volume:46 Page:1199-1209
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Chu Xiaojie¹²³,Li Yang¹²³,Huang Weiwei¹²³,Feng Xuejun¹²³,Sun Pengyan¹²³,Yao Yufeng¹²³,Yang Xu¹²³,Sun Wenjia¹²³,Bai Hongmei¹²³,Liu Cunbao¹²³,Ma Yanbing¹²³

Affiliation:

1. Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Kunming, China;

2. Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Disease, Kunming, China;

3. Yunnan Engineering Research Center of Vaccine Research and Development on Severe Infectious Disease, Kunming, China

Funder

the CAMS Initiative for Innovative Medicine

the Science and Technology Project of Yunnan Province

the National Natural Science Foundation of China

Fundamental Research Funds for Institute of Pathogen Biology of PUMC

the Peking Union Medical College (PUMC) Youth Fund and the Fundamental Research Funds for the Central Universities of China

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21691401.2018.1482306

Reference47 articles.

1. A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil^®)

2. Human Papillomavirus Types 16 and 18 Vaccine (Recombinant, AS04 Adjuvanted, Adsorbed) [Cervarix???]???

3. A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9–15-Year-Old Girls

4. Therapeutic human papillomavirus vaccines: current clinical trials and future directions

5. Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 1182 Modulating the tumor microenvironment by a targeting TGFB1 with vaccine-induced immune responses;Regular and Young Investigator Award Abstracts;2022-11

2. Distinct Responsiveness of Tumor-Associated Macrophages to Immunotherapy of Tumors with Different Mechanisms of Major Histocompatibility Complex Class I Downregulation;Cancers;2021-06-19

3. SQSTM1/p62 regulate breast cancer progression and metastasis by inducing cell cycle arrest and regulating immune cell infiltration;Genes & Diseases;2021-04

4. P. aeruginosa Mediated Necroptosis in Mouse Tumor Cells Induces Long-Lasting Systemic Antitumor Immunity;Frontiers in Oncology;2021-02-12

5. Cytotoxic T cells isolated from healthy donors and cancer patients kill TGFβ-expressing cancer cells in a TGFβ-dependent manner;Cellular & Molecular Immunology;2021-01-06